Autoimmunity Reviews

Papers
(The H4-Index of Autoimmunity Reviews is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases401
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome295
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study226
Editorial Board171
Editorial Board145
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis129
Cardiovascular disease risk in systemic lupus erythematous: Certainties and controversies129
Systemic lupus erythematosus and male reproductive health: A systematic review and meta-analysis97
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders88
Diagnostic approach in giant cell arteritis88
Maternal and fetal outcomes in Latin American SLE pregnancies: A systematic review and meta-analysis85
Human mesenchymal stem cells for the management of systemic sclerosis. Systematic review83
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation81
Editorial Board78
Rituximab-induced cystoid macular edema in a patient with systemic lupus erythematosus: A case report and literature review72
Inflammatory muscle involvement in systemic vasculitis: A systematic review69
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases68
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues66
Current landscape of monogenic autoinflammatory actinopathies: A literature review66
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis63
Genetic and genomic associations in antiphospholipid syndrome: A systematic review59
“Fibromyalgia syndrome” related to Essure devices59
Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review and meta-analysis58
Antiphospholipid antibodies and COVID-1956
Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review56
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis55
Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge54
Susac syndrome: A scoping review54
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians53
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis53
Role of regulatory T cells in inflammatory liver diseases52
Persistent aortic inflammation in patients with giant cell arteritis52
Editorial Board50
Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?48
TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review48
Editorial Board48
Leflunomide: A safe and effective alternative in systemic lupus erythematosus46
Rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis triggered by a 23-valent pneumococcal polysaccharide vaccine44
Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response43
Editorial Board43
From inflammation to renal fibrosis: A one-way road in autoimmunity?43
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target41
0.1042001247406